NO20084950L - Ny anvendelse av terapeutisk nyttige peptider - Google Patents

Ny anvendelse av terapeutisk nyttige peptider

Info

Publication number
NO20084950L
NO20084950L NO20084950A NO20084950A NO20084950L NO 20084950 L NO20084950 L NO 20084950L NO 20084950 A NO20084950 A NO 20084950A NO 20084950 A NO20084950 A NO 20084950A NO 20084950 L NO20084950 L NO 20084950L
Authority
NO
Norway
Prior art keywords
pro
therapeutically useful
new use
useful peptides
biologically active
Prior art date
Application number
NO20084950A
Other languages
English (en)
Norwegian (no)
Inventor
Tiina Jauhiainen
Riitta Korpela
Heikki Vapaatalo
Mats Ronnback
Original Assignee
Valio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Ltd filed Critical Valio Ltd
Publication of NO20084950L publication Critical patent/NO20084950L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/09—Other cheese preparations; Mixtures of cheese with other foodstuffs
    • A23C19/0921—Addition, to cheese or curd, of minerals, including organic salts thereof, trace elements, amino acids, peptides, protein hydrolysates, nucleic acids, yeast extracts or autolysate, vitamins or derivatives of these compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20084950A 2006-05-15 2008-11-25 Ny anvendelse av terapeutisk nyttige peptider NO20084950L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FI2006/050194 WO2007132054A1 (fr) 2006-05-15 2006-05-15 Nouvelle utilisation de peptides thérapeutiquement utiles

Publications (1)

Publication Number Publication Date
NO20084950L true NO20084950L (no) 2008-12-09

Family

ID=38693585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084950A NO20084950L (no) 2006-05-15 2008-11-25 Ny anvendelse av terapeutisk nyttige peptider

Country Status (8)

Country Link
US (1) US20090111758A1 (fr)
EP (1) EP2040732A4 (fr)
JP (1) JP2009537492A (fr)
CN (1) CN101443031A (fr)
AU (1) AU2006343802A1 (fr)
CA (1) CA2652388A1 (fr)
NO (1) NO20084950L (fr)
WO (1) WO2007132054A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090299036A1 (en) * 2006-02-14 2009-12-03 Calpis Co, Ltd Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
CN103275177B (zh) * 2013-06-24 2015-08-12 南京财经大学 具有肾素和ace双重抑制活性的小肽、其制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE402003C (sv) 1976-06-23 1982-02-22 Jonsereds Fabrikers Ab Anordning vid lastapparat med teleskopiskt forlengbar kranarm och med hydraulledningar uppburna av kranarmen
JPH064105A (ja) * 1992-06-17 1994-01-14 Yamaha Corp 誘導性負荷の駆動回路
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6069129A (en) 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
AU7501801A (en) 2000-05-30 2001-12-11 Connective Tissue Imagineering Composition and method for enhancing elasticity of tissue
GB0026134D0 (en) 2000-10-25 2000-12-13 Eurogene Ltd Peptides and their use
US6506129B2 (en) * 2001-02-21 2003-01-14 Archer C. C. Chen Golf club head capable of enlarging flexible area of ball-hitting face thereof
FI112031B (fi) * 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
EA011865B1 (ru) 2004-07-12 2009-06-30 ДСМ Ай Пи ЭССЕТС Б.В. Протеиновые гидролизаты, снижающие давление крови
US20090299036A1 (en) 2006-02-14 2009-12-03 Calpis Co, Ltd Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function

Also Published As

Publication number Publication date
JP2009537492A (ja) 2009-10-29
EP2040732A4 (fr) 2009-08-19
AU2006343802A1 (en) 2007-11-22
WO2007132054A1 (fr) 2007-11-22
CA2652388A1 (fr) 2007-11-22
US20090111758A1 (en) 2009-04-30
EP2040732A1 (fr) 2009-04-01
CN101443031A (zh) 2009-05-27

Similar Documents

Publication Publication Date Title
Wang et al. Hydrolysis and transport of egg white-derived peptides in Caco-2 cell monolayers and everted rat sacs
Ding et al. Transport of egg white ACE-inhibitory peptide, Gln-Ile-Gly-Leu-Phe, in human intestinal Caco-2 cell monolayers with cytoprotective effect
NO20076415L (no) GLP-1 pegylerte forbindelser
ES2949273T3 (es) Inhibidores de transglutaminasas
EA201000424A1 (ru) Антитела к il-23
Takagi et al. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity
NO20064388L (no) Kaseinavledede peptider og terapeutiske anvendelser derav
NO20080626L (no) Inhibitorer av fibroblastaktiverende protein alfa
FR2884717B1 (fr) Erythrocytes renfermant de l'arginine deiminase
NO20071714L (no) Fremgangsmateer for behandling av CD30 positive lymfomer
WO2003096984A3 (fr) Pharmacotherapie contre la maladie coeliaque
CL2008002092A1 (es) Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
TR200101769T2 (tr) Biyolojik maddelerin uygulanmasını kolaylaştıran cihazlar ve işlemler.
NO20084950L (no) Ny anvendelse av terapeutisk nyttige peptider
Vankadara et al. A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
Duan et al. Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells
NO20082098L (no) Formuleringer av AICA-ribosid
Higgins et al. Peptide transport by germinating barley embryos: uptake of physiological di-and oligopeptides
EA200701399A1 (ru) Сульфоны трипептидов и тетрапептидов
NO20084190L (no) Anvendelse av VX-702 til behandling av revmatoid artritt
CN110498832A (zh) 一组ace抑制肽及其应用
Shibata et al. Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide
WO2011021938A3 (fr) Régulation des fonds d'acides aminés utilisés pour la synthèse de protéines en phase aiguë
ATE554102T1 (de) Therapeutische verwendungen von monoklonalen antikörpern gegen den angiotensin-ii typ-1 rezeptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application